Sales rise 67.25% to Rs 34.22 crore
Net profit of Bafna Pharmaceuticals rose 75.88% to Rs 2.99 crore in the quarter ended December 2022 as against Rs 1.70 crore during the previous quarter ended December 2021. Sales rose 67.25% to Rs 34.22 crore in the quarter ended December 2022 as against Rs 20.46 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales34.2220.46 67 OPM %10.3713.83 -PBDT4.392.91 51 PBT2.991.70 76 NP2.991.70 76Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
